Clinical Trial: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Ator

Brief Summary:

The Torcetrapib project was terminated on December 2, 2006 due to safety findings.

To look at ultrasound images taken in the carotid arteries and to look at various lipids in the blood of people with mixed hyperlipidemia

Detailed Summary: For additional information please call: 1-800-718-1021
Sponsor: Pfizer

Current Primary Outcome: Change in intima media thickness as measured by carotid ultrasound

Original Primary Outcome: Same as current

Current Secondary Outcome: Changes in levels of lipids and other biomarkers.

Original Secondary Outcome: Same as current

Information By: Pfizer

Dates:
Date Received: August 22, 2005
Date Started: November 2003
Date Completion:
Last Updated: February 15, 2012
Last Verified: February 2012